Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome.

Rassen JA, Choudhry NK, Avorn J, Schneeweiss S.

Circulation. 2009 Dec 8;120(23):2322-9. doi: 10.1161/CIRCULATIONAHA.109.873497. Epub 2009 Nov 23.

PMID:
19933932
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.

Bhurke SM, Martin BC, Li C, Franks AM, Bursac Z, Said Q.

Pharmacotherapy. 2012 Sep;32(9):809-18. doi: 10.1002/j.1875-9114.2012.01112.x. Epub 2012 Jun 28.

PMID:
22744772
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.

Ray WA, Murray KT, Griffin MR, Chung CP, Smalley WE, Hall K, Daugherty JR, Kaltenbach LA, Stein CM.

Ann Intern Med. 2010 Mar 16;152(6):337-45. doi: 10.7326/0003-4819-152-6-201003160-00003.

PMID:
20231564
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.

Hsiao FY, Mullins CD, Wen YW, Huang WF, Chen PF, Tsai YW.

Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1043-9. doi: 10.1002/pds.2202. Epub 2011 Aug 8.

PMID:
21823195
[PubMed - indexed for MEDLINE]
5.

Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.

Lin CF, Shen LJ, Wu FL, Bai CH, Gau CS.

Br J Clin Pharmacol. 2012 Nov;74(5):824-34. doi: 10.1111/j.1365-2125.2012.04250.x.

PMID:
22364155
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SD.

Lancet. 2009 Sep 19;374(9694):989-97. doi: 10.1016/S0140-6736(09)61525-7. Epub 2009 Aug 31. Review.

PMID:
19726078
[PubMed - indexed for MEDLINE]
7.

Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.

Schmidt M, Johansen MB, Robertson DJ, Maeng M, Kaltoft A, Jensen LO, Tilsted HH, Bøtker HE, Sørensen HT, Baron JA.

Aliment Pharmacol Ther. 2012 Jan;35(1):165-74. doi: 10.1111/j.1365-2036.2011.04890.x. Epub 2011 Nov 4.

PMID:
22050009
[PubMed - indexed for MEDLINE]
8.

Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.

Banerjee S, Weideman RA, Weideman MW, Little BB, Kelly KC, Gunter JT, Tortorice KL, Shank M, Cryer B, Reilly RF, Rao SV, Kastrati A, de Lemos JA, Brilakis ES, Bhatt DL.

Am J Cardiol. 2011 Mar 15;107(6):871-8. doi: 10.1016/j.amjcard.2010.10.073. Epub 2011 Jan 19.

PMID:
21247527
[PubMed - indexed for MEDLINE]
9.

Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.

Charlot M, Ahlehoff O, Norgaard ML, Jørgensen CH, Sørensen R, Abildstrøm SZ, Hansen PR, Madsen JK, Køber L, Torp-Pedersen C, Gislason G.

Ann Intern Med. 2010 Sep 21;153(6):378-86. doi: 10.7326/0003-4819-153-6-201009210-00005. Erratum in: Ann Intern Med. 2011 Jan 4;154(1):76.

PMID:
20855802
[PubMed - indexed for MEDLINE]
10.

Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention.

Nakayama A, Morita H, Ando J, Fujita H, Ohtsu H, Nagai R.

Heart Vessels. 2013 May;28(3):292-300. doi: 10.1007/s00380-012-0248-3. Epub 2012 Mar 30.

PMID:
22460241
[PubMed - indexed for MEDLINE]
11.

One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.

Ortolani P, Marino M, Marzocchi A, De Palma R, Branzi A.

J Cardiovasc Med (Hagerstown). 2012 Dec;13(12):783-9. doi: 10.2459/JCM.0b013e3283416b6b.

PMID:
21252697
[PubMed - indexed for MEDLINE]
12.

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry DA, Kopp A, Mamdani MM.

CMAJ. 2009 Mar 31;180(7):713-8. doi: 10.1503/cmaj.082001. Epub 2009 Jan 28.

PMID:
19176635
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Risk of adverse clinical outcomes with concomitant use of clopidogrel and proton pump inhibitors following percutaneous coronary intervention.

Gupta E, Bansal D, Sotos J, Olden K.

Dig Dis Sci. 2010 Jul;55(7):1964-8. doi: 10.1007/s10620-009-0960-8.

PMID:
19731021
[PubMed - indexed for MEDLINE]
14.

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS.

JAMA. 2009 Mar 4;301(9):937-44. doi: 10.1001/jama.2009.261.

PMID:
19258584
[PubMed - indexed for MEDLINE]
15.

Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.

Burkard T, Kaiser CA, Brunner-La Rocca H, Osswald S, Pfisterer ME, Jeger RV; BASKET Investigators.

J Intern Med. 2012 Mar;271(3):257-63. doi: 10.1111/j.1365-2796.2011.02423.x. Epub 2011 Aug 11.

PMID:
21726302
[PubMed - indexed for MEDLINE]
16.

Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.

Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K.

Thromb Haemost. 2010 Dec;104(6):1211-8. doi: 10.1160/TH10-04-0218. Epub 2010 Oct 12.

PMID:
20941464
[PubMed - indexed for MEDLINE]
17.

Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.

Mahabaleshwarkar RK, Yang Y, Datar MV, Bentley JP, Strum MW, Banahan BF, Null KD.

Curr Med Res Opin. 2013 Apr;29(4):315-23. doi: 10.1185/03007995.2013.772051. Epub 2013 Feb 11.

PMID:
23362935
[PubMed - indexed for MEDLINE]
18.

Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.

Aihara H, Sato A, Takeyasu N, Nishina H, Hoshi T, Akiyama D, Kakefuda Y, Watabe H, Aonuma K; ICAS Registry Investigators.

Catheter Cardiovasc Interv. 2012 Oct 1;80(4):556-63. doi: 10.1002/ccd.23327. Epub 2012 Jan 10.

PMID:
22234956
[PubMed - indexed for MEDLINE]
19.

Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.

Stockl KM, Le L, Zakharyan A, Harada AS, Solow BK, Addiego JE, Ramsey S.

Arch Intern Med. 2010 Apr 26;170(8):704-10. doi: 10.1001/archinternmed.2010.34.

PMID:
20421557
[PubMed - indexed for MEDLINE]
20.

Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.

Kreutz RP, Stanek EJ, Aubert R, Yao J, Breall JA, Desta Z, Skaar TC, Teagarden JR, Frueh FW, Epstein RS, Flockhart DA.

Pharmacotherapy. 2010 Aug;30(8):787-96. doi: 10.1592/phco.30.8.787.

PMID:
20653354
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk